durapatite has been researched along with teriflunomide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, FJ; Kumar, V; Leekha, A; Pandey, S; Rai, N; Talegaonkar, S; Verma, AK | 1 |
| Ahmad, FJ; Mahtab, A; Mittal, D; Neupane, YR; Pandey, S; Rai, N; Sandal, N; Talegaonkar, S; Verma, AK | 1 |
2 other study(ies) available for durapatite and teriflunomide
| Article | Year |
|---|---|
Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Crotonates; Drug Carriers; Drug Combinations; Drug Compounding; Drug Liberation; Drug Stability; Durapatite; Female; Hydrogen-Ion Concentration; Hydroxybutyrates; Kinetics; Methotrexate; Nanoparticles; Nitriles; Oxidative Stress; Particle Size; Rats; Rats, Wistar; Tissue Distribution; Toluidines | 2018 |
Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Crotonates; Cytokines; Drug Carriers; Drug Evaluation, Preclinical; Drug Liberation; Durapatite; Hyaluronic Acid; Hydroxybutyrates; Liver; Methotrexate; Mice; Nanoparticles; Nitriles; Rats; Rats, Wistar; RAW 264.7 Cells; Spectroscopy, Fourier Transform Infrared; Tissue Distribution; Toluidines | 2021 |